If you are not happy with the results below please do another search
The series of learning notes in this book highlights the Breakthrough ACTION for COVID-19 program in Indonesia. All of these records are expected to provide inspiration regarding efforts to make behavioral and social changes in the wider community; so that program managers can apply proven good practices or mitigate when implementing various other programs.
Starting from an analysis of communication in Italy during the COVID-19 emergency period (February–June 2020), this paper provides an overview of the main challenges and opportunities for communication during pandemics. The purpose of this study is to perform a literature review contributing to the identification of practical recommendations for the improvement of current risk communication strategies.
This review aims to assess whether the common clinical features of COVID-19 have changed to the point that the criteria used to identify both COVID-19 and influenza in surveillance programs needs to be altered.
This series of cross-sectional studies explores the effect of the COVID-19 pandemic on demand- and supply-side factors affecting maternal, newborn, and child health (MNCH) service utilization in Kenya, Malawi and Mozambique.
This Program Brief describes how Breakthrough ACTION Nigeria used theory-based programming to drive vaccine uptake through social and behavior change programming.
This analysis focuses on a subset of data relating to perceptions of COVID-19 among pregnant women in Côte d’Ivoire. The Breakthrough ACTION team, in partnership with the Department of Health and USAID, collected qualitative data from three sites to assess concern about COVID-19, perceptions of the current vaccine rollout, standards perceptions around vaccination, how misinformation and other factors influence vaccine uptake.
The Breakthrough ACTION project through USAID funding, supports the government of Côte d’Ivoire through social and behavior change (SBC) interventions, including research and monitoring to inform COVID-19 vaccination activities. Breakthrough ACTION collected qualitative data across three sites (Abidjan – Bouaké – San Pedro) to assess perceptions of the COVID-19 vaccine.
Since the emergence of the SARS-CoV2 virus and its first detection in Côte d’Ivoire in March 2020, the country has recorded 87,891 cases and 830 deaths (November 2022). The Ministry of Health has taken various measures to reduce the spread and impact of COVID-19, including the authorization of COVID-19 vaccines AstraZeneca, Pfizer, Sinopharm and Johnson & Johnson (J&J). With some ambitious goals to vaccinate 70% of the Ivorian population, understanding the drivers of confidence and uptake of vaccines is essential for the response to COVID-19 and achieving this goal.
A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The increase was not associated with any change in the number of days of menses (days of bleeding).
This revised Roadmap takes into account increasing vaccine availability, vaccine coverage rates, and the evolving epidemiological situation including COVID-19 variants of concern.
To assist countries in developing recommendations for optimized use of vaccines against COVID-19, priority-use groups for vaccination (both primary series and booster doses) are identified based on epidemiological scenarios, public health goals, and vaccine coverage scenarios.
This website is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the Breakthrough ACTION Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at Johns Hopkins Center for Communication Programs (CCP).The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or Johns Hopkins University.
